Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Other Accumulated Expenses (2021)

International Stem Cell (ISCO) has disclosed Other Accumulated Expenses for 1 consecutive years, with $300000.0 as the latest value for Q4 2021.

  • On a quarterly basis, Other Accumulated Expenses changed N/A to $300000.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $300000.0, a N/A change, with the full-year FY2021 number at $300000.0, changed N/A from a year prior.
  • Other Accumulated Expenses was $300000.0 for Q4 2021 at International Stem Cell.
  • In the past five years, Other Accumulated Expenses ranged from a high of $300000.0 in Q4 2021 to a low of $300000.0 in Q4 2021.